![Michelle Lock](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Michelle Lock worked as a Director at RELIEF THERAPEUTICS Holding SA from 2022 to 2024.
She also held the position of Senior Vice President, Head-Europe & International at Acceleron Pharma, Inc. and Chief Operating Officer at Covis Pharma Holdings BV.
Eerdere bekende functies van Michelle Lock
| Bedrijven | Functie | Einde |
|---|---|---|
| MINDMAZE THERAPEUTICS HOLDING SA | Algemeen Directeur | 31-05-2024 |
Covis Pharma Holdings BV
 Covis Pharma Holdings BV Pharmaceuticals: MajorHealth Technology Engages in the manufacturing and distribution of specialty pharmaceuticals | Operationeel Directeur | - |
| ACCELERON PHARMA INC. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
14
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Covis Pharma Holdings BV
Covis Pharma Holdings BV Pharmaceuticals: MajorHealth Technology Engages in the manufacturing and distribution of specialty pharmaceuticals | Health Technology |
RELIEF THERAPEUTICS Holding SA
 RELIEF THERAPEUTICS Holding SA Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of biopharmaceutical products for respiratory diseases | Health Technology |
